Mental Health

Examining the Impact of the COVID-19 Pandemic on Treatment, Symptoms and Lifestyle, Among Outpatient Psychiatric Patients

Although several studies have looked at the impact of pre-existing mental illness and COVID-19 among the general public, no current studies have investigated the impact of COVID-19 among outpatient psychiatric patients. This study will investigate how outpatient psychiatric adults & children are affected with the mental health challenges posed by COVID-19 and its impact on other aspects of their lives.

Primary disease category:

An experimental drug for OCD

The study seeks to explore the benefits of an experimental drug as a potential new treatment of obsessive-compulsive disorder (OCD). The experimental drug changes activity in brain areas believed to be involved in OCD.

This study will involve approximately 8-10 weeks of study participation, including eight weeks of investigational treatment.

Primary disease category:

Secondary disease category(ies):

Emotional State and Personality: A Proof-of-Concept Model for Predicting Performance Under Stress

The SCAN Lab is conducting a study at the University of Arizona to look at how personality traits and emotional responses during stress can influence performance on cognitive tasks.

Primary disease category: